NAFDAC Registry Watch — October 2026
What changed in the register we track, found by comparing our monthly copies of the NAFDAC Greenbook: products newly published, listings renewed back to Active, and listings our copy no longer records as Active.
New in the Greenbook
Approval dates can be earlier than the month a product appears — NAFDAC approves first, the Greenbook publishes on its own schedule.
1 product entered our copy between the previous snapshot and October 2026.
| Product | Reg. no. | Applicant | Composition | Approved |
|---|---|---|---|---|
| ALBEN AMLODIPINE 10MG TABLET $1 | A11-0432 | Alben Health Care Industries Ltd | 10mg | 2026-03-31 |
No longer listed as Active
1 listing recorded as Active in our previous copy carries a different status in our October 2026 copy.
| Product | Reg. no. | Recorded change | Verify |
|---|---|---|---|
| Nucrest Cream | A4-100134 | “Active” → “Inactive” | verify current status |
A further 1 listing moved between non-Active statuses (for example “Inactive” to “Expired”) — recorded in our ledger but not listed here.
Compiled from our October 2026 copy of the NAFDAC Greenbook. “New” means newly present in the register copy we track, not necessarily newly approved; status changes are quoted verbatim from our copies and can lag the live register. Verify any number free with the NAFDAC checker.
The years in review
The monthly watch, accumulated: what each completed year added to the register — totals, busiest months, top registrants, and where that year's medicines were made.